Source : investing, Tuesday, 2024/9/24
BofA Securities began its coverage of National Health Investors (NYSE:NHI) shares, giving it a “buy” rating and setting a target price of $92.00. The company’s valuation is based on the Adjusted Money from Operations (AFFO) multiplier, applying a 19x multiple to its estimate of AFFO for 2025 of $4.85 per share.
The chosen multiplier reflects the National Health Investors’ mix of operating housing for the elderly (SHOP) and skilled nursing/elderly housing (SH/SNF) assets leased netly compared to their industry peers.
The BofA Securities multiplier is higher than its net leasing counterparts such as OHI and SBRA, and lower than its SHOP counterparts that include WELL, VTR, and AHR. This position is due to the composition of the National Health Investors portfolio and expectations for external growth.
The analyst pointed to the potential risk of a rise in price target that may stem from increased expansion of SHOP and higher volumes or more favorable capitalization rates in acquisitions..
The start of hedging and setting the target price comes as investors assess the company’s financial outlook and strategic location within the health real estate sector. The market will continue to keep an eye on National Health Investors stock as it responds to the factors identified by BofA Securities.
National Health Investors has made great strides in the market. The company exceeded expectations for the second quarter, marking the fourth consecutive quarter of exceeding expectations.
This success is attributed to a significant increase in net operating income (NOI) for the operating elderly housing portfolio, which saw a 39.9% year-on-year increase. In response to these strong results, National Health Investors raised its full-year forecast and closed investments worth $56.6 million this year..
In addition to these financial achievements, National Health Investors announced a subscribed public offering of 2 million of its ordinary shares. The book managers involved in this transaction are BofA Securities, J.P. Morgan, Wells Fargo Securities and BMO Capital Markets.
Despite these positive developments, Truist Securities maintains a conservative view of the future performance of National Health Investors’ stock. The company raised its price target to $78.00 from the previous $65.00 but retained a “hold” rating on the company.
With BofA Securities starting its coverage of National Health Investors (NYSE:NHI) with a positive outlook, real-time data from InvestingPro further enriches the investment perspective. National Health Investors are currently trading at P/E is 28.79, indicating a relatively high valuation compared to near-term earnings growth. This is in line with the BofA valuation method, which applies a relatively higher multiplier compared to its net leasing counterparts. With a market capitalization of $3.91 billion, the company shows a strong financial position..
InvestingPro’s advice suggests that analysts have revised earnings forecasts upwards for the coming period, suggesting potential optimism about the company’s future performance. In addition, National Health Investors has maintained dividend payments for 34 consecutive years, which could appeal to income-focused investors. The company’s shares are trading near a 52-week high, with a one-year overall price return of 75.58%, reflecting confidence Strong from investors and good performance in the market.
